3,5-diisopropylsalicylic acid has been researched along with Grippe in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hein, MD; Kupke, SY; Marichal-Gallardo, P; Marsall, P; Pelz, L; Piagnani, E; Reichl, U; Wynserski, N | 1 |
| Baelkner, M; Benndorf, D; Boehme, JD; Bruder, D; Dogra, T; Genzel, Y; Gruber, AD; Hein, MD; Kershaw, O; Kuechler, J; Kupke, SY; Marichal-Gallardo, P; Pelz, L; Reichl, U | 1 |
2 other study(ies) available for 3,5-diisopropylsalicylic acid and Grippe
| Article | Year |
|---|---|
Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Coinfection; Defective Interfering Viruses; Humans; Influenza A virus; Influenza, Human; Vero Cells; Virus Replication; Yellow Fever; Zika Virus; Zika Virus Infection | 2023 |
Generation of "OP7 chimera" defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice.
Topics: Animals; Antiviral Agents; Coinfection; Defective Viruses; Humans; Influenza A virus; Influenza, Human; Mice; Virus Replication | 2023 |